Used in pharmaceutical research as an intermediate for developing enzyme inhibitors, particularly in studies targeting inflammatory pathways and metabolic disorders. Its structure supports binding to specific protein active sites, making it valuable in the design of potential anti-inflammatory or antidiabetic agents. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates due to its cyclohexyl and fluorophenyl moieties, which enhance metabolic stability and target affinity.